The popularity of Sildenafil initially drove a period of growth for the drug industry, however recent shifts present a uncertain picture for investors. Lower-cost alternatives are eating into revenue, and ongoing https://aprilozlk709025.blog2freedom.com/41284508/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-bet